Table 2.
Mean before matching |
Mean after matching |
|||||
---|---|---|---|---|---|---|
CU+ Group (n = 519) | CU− Group (n = 8,880) | SMD | CU+ Group (ESS = 519, n = 519) | CU− Group (ESS = 820.6, n = 8,880) | SMD | |
Distance | 0.153 | 0.050 | 0.712 | 0.153 | 0.153 | 0.000 |
Mean maternal age, y | 30.573 | 31.979 | −0.291 | 30.57 | 30.595 | −0.005 |
Ethnicity | ||||||
Biracial | 0.027 | 0.025 | 0.010 | 0.027 | 0.028 | −0.007 |
Black | 0.012 | 0.012 | −0.002 | 0.012 | 0.010 | 0.018 |
East or Southeast Asian | 0.017 | 0.033 | −0.122 | 0.017 | 0.010 | 0.060 |
Hispanic | 0.017 | 0.019 | −0.016 | 0.017 | 0.021 | −0.028 |
Indigenous | 0.077 | 0.024 | 0.198 | 0.077 | 0.065 | 0.046 |
South Asian | 0.004 | 0.028 | −0.987 | 0.004 | 0.005 | −0.017 |
West Asian | 0.004 | 0.011 | −0.109 | 0.004 | 0.002 | 0.029 |
White | 0.842 | 0.848 | −0.015 | 0.842 | 0.860 | −0.049 |
Income, CAD | ||||||
<$70,000 | 0.459 | 0.192 | 0.535 | 0.459 | 0.441 | 0.035 |
$70,000-$99,999 | 0.195 | 0.197 | −0.007 | 0.195 | 0.213 | −0.047 |
$100,000-$124,999 | 0.139 | 0.192 | −0.154 | 0.139 | 0.153 | −0.041 |
$125,000-$174,999 | 0.146 | 0.249 | −0.290 | 0.146 | 0.149 | −0.008 |
≥$175,000 | 0.062 | 0.170 | −0.449 | 0.062 | 0.043 | 0.076 |
Relationship status | ||||||
Marriage-like | 0.484 | 0.322 | 0.324 | 0.484 | 0.509 | −0.051 |
Married | 0.407 | 0.639 | −0.474 | 0.407 | 0.377 | 0.060 |
Single | 0.110 | 0.039 | 0.226 | 0.110 | 0.114 | −0.013 |
Symptoms of depression | ||||||
Clinically elevated | 0.547 | 0.321 | 0.455 | 0.547 | 0.535 | 0.025 |
Not elevated | 0.453 | 0.679 | −0.455 | 0.453 | 0.465 | −0.025 |
Symptoms of anxiety | ||||||
Clinically severe | 0.143 | 0.065 | 0.221 | 0.143 | 0.116 | 0.076 |
Clinically moderate | 0.516 | 0.394 | 0.244 | 0.516 | 0.522 | −0.012 |
Clinically mild | 0.125 | 0.214 | −0.269 | 0.125 | 0.123 | 0.006 |
Not elevated | 0.216 | 0.326 | −0.268 | 0.216 | 0.238 | −0.055 |
Alcohol use during pregnancy | 0.299 | 0.118 | 0.394 | 0.299 | 0.303 | −0.010 |
Tobacco use during pregnancy | 0.281 | 0.041 | 0.535 | 0.281 | 0.286 | −0.010 |
Child sexa | ||||||
Female | 0.224 | 0.290 | −0.067 | 0.224 | 0.227 | −0.003 |
Male | 0.260 | 0.316 | −0.056 | 0.260 | 0.264 | −0.004 |
Other | 0.002 | 0.000 | 0.002 | 0.002 | 0.000 | 0.002 |
Not reported | 0.514 | 0.393 | 0.121 | 0.514 | 0.509 | 0.005 |
COVID-19 infectiona | ||||||
Confirmed negative | 0.073 | 0.095 | −0.022 | 0.073 | 0.076 | −0.003 |
Confirmed positive | 0.004 | 0.005 | −0.001 | 0.004 | 0.001 | 0.003 |
Not reported | 0.923 | 0.900 | 0.023 | 0.923 | 0.923 | 0.000 |
Note: CU+ = Participants who reported cannabis use during pregnancy; CU− = participants who did not report cannabis use during pregnancy; ESS = effective sample size; SMD = standard mean difference.
Participants were not matched on this variable.